Scilex Holding Company (SCLX) - News Archive

In a significant leap forward for the pharmaceutical landscape, Scilex Holding Company (Nasdaq: SCLX) has announced two key developments that underline its commitment to innovative pain management solutions. Recently, t...

IntroductionScilex Holding Company, a revenue-generating company dedicated to non-opioid pain management, has announced the appointment of Dr. Annu Navani to its Board of Directors. This move highlights the company s co...

Scilex Holding Company Collaborates with ACEA Therapeutics to Expand ZTlido Program in Greater China Region By PALO ALTO, Calif., July 17, 2024 Scilex Holding Company (Nasdaq: SCLX) a forward-looking, revenue-generating...

Over the past few weeks, Scilex Holding Co, a renowned biopharmaceutical company, has made significant strides towards securing financial stability and strengthening its market position. These initiatives come at a crit...

PALO ALTO, Calif., June 20, 2024 - As the healthcare industry continues to grapple with the opioid epidemic, Scilex Holding Company (Nasdaq: SCLX) emerges as a beacon of hope, revolutionizing pain management with their...

Scilex Holding Company Unveils Promising Phase 3 Trial Results and Strategic Advances in Pain Management and Gout Treatment Scilex Holding Company Accelerates Non-Opioid Therapeutic Innovations PALO ALTO, Calif., June 1...

PALO ALTO, Calif., June 13, 2024 Scilex Holding Company (Nasdaq: SCLX), renowned for its commitment to developing and commercializing non-opioid pain management products, is set to make significant strides in the treatm...

In a move to strengthen its position in the non-opioid pain management market, Scilex Holding Company recently announced a significant development. The company has entered into a commitment letter with Perigrove LLC and...

Scilex Holding Company, a leading player in non-opioid pain management products, has recently made significant strides in expanding its market presence and enhancing patient accessibility. With the launch of GLOPERBA, t...

Scilex Holding Company: Pioneering Non-Opioid Pain Management Solutions and Ensuring Affordable Access Across the U.S. PALO ALTO, Calif. June 10, 2024Scilex Holding Company (Nasdaq: SCLX), an innovative revenue-generati...

Scilex Holding Company Receives FDA Approval for Commercial Manufacturing of Gloperba, a Revolutionary Treatment for Painful Gout FlaresPALO ALTO, Calif., June 6, 2024 - Scilex Holding Company (Nasdaq: SCLX), a leading...

In a bold move to protect its shareholders and maintain integrity in the market, Scilex Holding Company has sent official letters to both the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regu...

Scilex Holding Company, a prominent player in the field of non-opioid pain management therapeutics, has recently announced its inclusion in the MSCI Global Microcap Index. This development is expected to significantly e...

Scilex Holding Company, an innovative firm focused on acquiring, developing, and commercializing non-opioid pain management products, has declared the end of a Paragraph IV patent infringement lawsuit that Takeda Pharma...

In recent years, the practice of short selling has attracted significant attention due to its potential impact on the stability of the financial markets and individual companies. Scilex Holding Company, an innovative ph...

Scilex Holding Company Closes $15 Million Offering, Company Shares Drop 52%Scilex Holding Company recently announced the successful closing of a $15 million registered direct offering of common stock and warrants. The o...

Palo Alto-based Scilex Holding Company, a revenue-generating firm specializing in non-opioid pain management products, has recently finalized a definitive agreement with institutional investors for the purchase and sale...

The pharmaceutical landscape has been gifted a breath of fresh air as Scilex Holding Company, an entity notorious for its dedicated investment in acquiring, developing, and commercializing non-opioid pain management pro...

Scilex Holding Company, a leading player in the non-opioid pain management product market, has recently announced that the U.S. Bankruptcy Court for the Southern District of Texas has extended the lockup period on share...

Scilex Holding Company, an innovative revenue-generating company specializing in non-opioid pain management products, has announced several significant developments. The company has capped out-of-pocket costs for commer...